During the recent session, Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s traded shares were 1.16 million, with the beta value of the company hitting 1.55. At the last check today, the stock’s price was $0.66, reflecting an intraday loss of -10.45% or -$0.07. The 52-week high for the CTXR share is $1.56, that puts it down -136.36 from that peak though still a striking 9.09% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $104.37M, and the average trade volume was 842.91K shares over the past three months.
Citius Pharmaceuticals Inc (NASDAQ:CTXR) trade information
Citius Pharmaceuticals Inc (CTXR) registered a -10.45% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -10.45% in intraday trading to $0.66, hitting a weekly high. The stock’s 5-day price performance is -13.03%, and it has moved by -20.39% in 30 days. Based on these gigs, the overall price performance for the year is -52.80%.
Citius Pharmaceuticals Inc (CTXR) estimates and forecasts
Statistics show that Citius Pharmaceuticals Inc has outperformed its competitors in share price, compared to the industry in which it operates. Citius Pharmaceuticals Inc (CTXR) shares have gone down -15.68% during the last six months, with a year-to-date growth rate more than the industry average at 12.50% against 10.40.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 14.81M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 15.43M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 28.21%. While earnings are projected to return 0.00% in 2024.
CTXR Dividends
Citius Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
